查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
皮膚替代品市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按類型、按應用、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1326474

皮膚替代品市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按類型、按應用、最終用戶、地區和競爭細分

Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

由於對先進傷口護理產品的需求不斷成長以及該領域的技術進步，全球皮膚替代品市場預計在預測期內將以驚人的速度成長。全球皮膚替代品市場是醫療行業快速成長的部分。皮膚替代品用於替代患者受損或缺失的皮膚，在燒傷、慢性傷口和其他皮膚損傷的治療中變得越來越重要。據 Joye 律師事務所稱，美國每年報告約 45 萬起燒傷事故。在美國，約有 45,000 人因燒傷住院，其中約 25,000 人被送往專門的燒傷中心。

皮膚替代品的優點

皮膚替代品的主要優點之一是它們能夠促進傷口癒合和預防感染。皮膚替代品能夠在傷口上形成保護屏障，防止進一步損傷並讓身體專注於癒合。它們還為新皮膚細胞的生長提供了框架，並有助於減少疤痕。皮膚替代品的另一個優點是其多功能性。皮膚替代品可用於多種醫療領域，並且可以客製化以滿足每個患者的需求。它們可用於治療各種皮膚損傷，從小割傷和擦傷到大燒傷。此外，皮膚替代品是現代醫學的一個重要方面，並已被證明在治療嚴重皮膚損傷時可以挽救生命。它們可用於各種醫療領域，並可進行客製化以滿足每個患者的需求。皮膚替代品的發展徹底改變了皮膚損傷的治療方法，並顯著改善了患者的治療效果。與皮膚替代品相關的所有這些優勢預計將在未來幾年推動全球皮膚替代品市場的成長。

幹細胞在皮膚替代品中的應用

近年來，隨著研究人員和醫療專業人員尋求提高這些產品在治療一系列皮膚損傷方面的有效性，皮膚替代品領域出現了一些關鍵發展。這些開發旨在創造更有效、更通用、更易於使用的新產品，並可能在該領域的未來發揮重要作用。皮膚替代品領域的一項關鍵發展是幹細胞的使用。幹細胞是能夠發育成體內許多不同類型細胞的細胞，並且有可能幫助再生受損或缺失的組織。研究人員一直在探索幹細胞在皮膚替代品中的應用，並取得了有希望的結果。目前市場上的一些產品將幹細胞融入皮膚替代品中，有助於提高癒合速度和品質。

3D 列印在皮膚替代品中的應用

3D 列印可以創建複雜的、客製化設計的皮膚替代品，可以根據個別患者的需求進行客製化。這項技術有可能徹底改變該領域，使製造高品質、有效的皮膚替代品變得更加容易，這些替代品用途更廣泛、更易於使用。蓬勃發展的3D列印行業預計將在預測期內為全球皮膚替代品市場的成長創造新的前景。多年來，擁有集中式3D列印設施的醫院數量從2010年的3家增加到2019年的100家。

個性化醫療日益普及

皮膚替代品領域的一個重要趨勢是日益關注個性化醫療。多年來，個性化醫療的受歡迎程度顯著增加。 2010年有36種藥物可供使用，但到2020年已有286種藥物可供使用。越來越多的個性化藥物獲得批准並在治療不同類型的慢性和急性傷口方面越來越受歡迎，預計將為未來幾年全球皮膚替代品市場的成長開闢新的前景。個性化醫療涉及皮膚替代品或傷口護理，涉及根據每位患者的個人需求客製化治療方案，並考慮年齡、性別和其他健康狀況等因素。通過專注於個性化醫療，研究人員希望創造出更有效、更高效的皮膚替代品，有助於改善患者的治療效果。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：臨床試驗分析

  • 正在進行的臨床試驗
  • 已完成的臨床試驗
  • 終止的臨床試驗
  • 按開發階段分類的管道細目
  • 管道細分（按狀態）
  • 按研究類型分類的管道細目
  • 按地區分類的管道明細
  • 臨床試驗熱圖

第 6 章：全球皮膚替代品市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖
    • 按類型
    • 按應用
    • 按最終用戶
    • 按地區

第 7 章：北美皮膚替代品市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 8 章：歐洲皮膚替代品市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 9 章：亞太皮膚替代品市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 10 章：南美洲皮膚替代品市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章：中東和非洲皮膚替代品市場前景

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（生物與合成）
    • 按應用（急性傷口與慢性傷口）
    • 按最終用戶（醫院和診所、門診手術中心、其他）
    • 按國家/地區
  • MEA：國家分析
    • 南非皮膚替代品
    • 沙烏地阿拉伯皮膚替代品
    • 阿拉伯聯合大公國皮膚替代品

第 12 章：市場動態

  • 司機
  • 挑戰

第 13 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 14 章：全球皮膚替代品市場：SWOT 分析

第 15 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第16章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
    • Amarantus BioScience Holdings, Inc.
    • Organogenesis, Inc
    • Acelity LP, Inc.
    • Smith & Nephew plc
    • BSN Medical GmbH
    • Molnlycke Health Care ABss
    • Integra LifeSciences Corporation
    • Medtronic Plc
    • Tissue Regenix Ltd.
    • Stratatech Corporation

第 17 章：戰略建議

簡介目錄
Product Code: 14831

Global Skin Substitutes Market is expected to grow at an impressive rate during the forecast period on account of the increasing demand for advanced wound care products and technological advancements in the field. Global Skin Substitutes Market is a rapidly growing segment of the medical industry. Skin substitutes, which are used to replace damaged or missing skin in patients, have become increasingly important in the treatment of burns, chronic wounds, and other skin injuries. According to Joye Law Firm, around 450,000 burn injuries are reported every year in the United States. Around 45,000 people are hospitalized because of burn injuries in the United States, of which about 25,000 are admitted to specialized burn centers.

The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is one of the major factors driving the growth of the market. Additionally, the rising incidence of burns and other traumatic injuries is also contributing to the growth of the market. The annual incidence of diabetic foot ulcers worldwide is between 9.1 to 26.1 million. About 15 to 25% of patients suffering from diabetes mellitus tend to develop diabetic foot ulcers during their lifetime.

Skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. These substitutes are used to replace damaged or missing skin in patients and can be utilized in a variety of medical fields, including plastic surgery, dermatology, and burn care. Additionally, key developments in the field of skin substitutes, such as the use of advanced materials, such as nanofibers and hydrogels, and the development of new manufacturing techniques that allow for the creation of products that are more consistent and reliable. These advances are likely to lead to the creation of products that are more effective in treating a wider range of skin injuries. This, in turn, is expected to create lucrative opportunities for the growth of global skin substitutes market in the coming years.

Advantages Associated with Skin Substitutes

One of the major advantages of skin substitutes is their ability to promote wound healing and prevent infection. Skin substitutes are able to create a protective barrier over the wound, preventing further damage and allowing the body to focus on healing. They also provide a framework for new skin cells to grow and can help reduce scarring. Another advantage of skin substitutes is their versatility. Skin substitutes can be used in a variety of medical fields and can be customized to meet the needs of each patient. They can be used to treat a variety of skin injuries, from small cuts and scrapes to large burn injuries. Additionally, skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. They can be used in a variety of medical fields and can be customized to meet the needs of each patient. The development of skin substitutes has revolutionized the treatment of skin injuries and has significantly improved patient outcomes. All these advantages associated with skin substitutes are expected to drive the growth of global skin substitutes market in the coming years.

Use of Stem Cells in the Skin Substitutes

The field of skin substitutes has seen several key developments in recent years as researchers and medical professionals seek to improve the effectiveness of these products in treating a range of skin injuries. These developments are aimed at creating new products that are more effective, more versatile, and easier to use and are likely to play an important role in the future of the field. One key development in the field of skin substitutes has been the use of stem cells. Stem cells are cells that have the ability to develop into many different types of cells in the body and have the potential to help regenerate damaged or missing tissue. Researchers have been exploring the use of stem cells in skin substitutes, with promising results. Some products on the market today incorporate stem cells into the skin substitute, helping to improve the speed and quality of healing.

Use of 3D Printing in the Skin Substitutes

3D printing allows for the creation of complex, custom-designed skin substitutes that can be tailored to the needs of individual patients. This technology has the potential to revolutionize the field, making it easier to create high-quality, effective skin substitutes that are more versatile and easier to use. The flourishing 3D printing industry is expected to create new prospects for the growth of global skin substitutes market during the forecast period. Over the years, the number of hospitals with a centralized 3D printing facility increased to 100 in 2019 from just three in 2010.

Growing Popularity of Personalized Medicine

One important trend in the field of skin substitutes is the increasing focus on personalized medicine. The popularity of personalized medicine has increased significantly over the years. In 2010 there were 36 medicines available, but in 2020 there were already 286 medicines available. The increasing number of personalized medicines getting approval and gaining popularity in terms of usage for the treatment of different kinds of chronic and acute wounds is expected to open new prospects for the growth of global skin substitutes market in the next few years. The involvement of personalized medicine in skin substitutes or wound care involves tailoring treatments to the individual needs of each patient and taking into account factors such as age, gender, and other health conditions. By focusing on personalized medicine, researchers hope to create skin substitutes that are more effective and efficient and that can help improve patient outcomes.

Market Segmentation

Global Skin Substitutes Market can be segmented by type, application, end-user, and by region. Based on type, global skin substitutes market can be divided into biological and synthetic. Biological skin substitutes can be further categorized into autografts, allografts, and xenografts. In terms of application, global skin substitutes can be categorized into acute wounds and chronic wounds. Based on end users, the global skin substitutes market can be segmented into hospitals & clinics, ambulatory surgery centers, and others. Regionally, the global skin substitutes market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. United States dominated the global skin substitute market in 2022 in terms of all the countries owing to the increasing number of people getting injured in fire accidents in the United States. Around 3,500 people get fatally injured in a fire or burn accident every year in the United States, requiring the use of skin substitutes for treatment purposes, thereby driving the growth of global skin substitutes market.

Market Players

Amarantus BioScience Holdings, Inc., Organogenesis, Inc, Acelity L.P., Inc., Smith & Nephew plc, BSN Medical GmbH, Molnlycke Health Care AB, Integra LifeSciences Corporation, Medtronic Plc, Tissue Regenix Ltd., Stratatech Corporation, among others, are some of the leading players operating in the global skin substitutes market. The field of skin substitutes has seen a number of exciting new product launches in recent years as companies develop new and innovative products designed to improve the treatment of a range of skin injuries. These product launches are aimed at creating new solutions that are more effective, more versatile, and easier to use and are likely to have a major impact on the future of the global skin substitute market.

  • In November 2022, AVITA Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) had granted the company's autologous cellular therapy device for skin restoration, RECELL SYSTEM, a designation of breakthrough device. This breakthrough status will help in increasing access to RECELL SYSTEM for both patients and healthcare providers.
  • In August 2022, Organogenesis, Inc. announced that it had received U.S. Food and Drug Administration (FDA) 510k Clearance for PuraPly MZ. PuraPly MZ is based on the company's PuraPly technology, engineered into a micronized (powdered) form to provide surgeons with an option for complex surgical wounds.

Report Scope:

In this report, Global Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Skin Substitutes Market, By Type:

  • Biological
  • Autografts
  • Allografts
  • Xenografts
  • Synthetic

Skin Substitutes Market, By Application:

  • Acute Wounds
  • Chronic Wounds

Skin Substitutes Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Skin Substitutes Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Skin Substitutes Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Skin Substitute Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Biological v/s Synthetic)
      • 6.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 6.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Product Map
    • 6.3.1 By Type
    • 6.3.2 By Application
    • 6.3.3 By End User
    • 6.3.4 By Region

7. North America Skin Substitute Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Biological v/s Synthetic)
      • 7.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 7.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 7.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Skin Substitute Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Skin Substitute Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Skin Substitute Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Skin Substitute Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Biological v/s Synthetic)
      • 8.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 8.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 8.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Skin Substitute Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Skin Substitute Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Skin Substitute Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Skin Substitute Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Skin Substitute Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Skin Substitute Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Biological v/s Synthetic)
      • 9.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 9.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 9.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Skin Substitute Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Skin Substitute Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Skin Substitute Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Skin Substitute Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Skin Substitute Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Skin Substitute Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Biological v/s Synthetic)
      • 10.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 10.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 10.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Skin Substitute Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Skin Substitute Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Skin Substitute Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Skin Substitute Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Biological v/s Synthetic)
      • 11.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 11.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 11.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Skin Substitute Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Skin Substitute Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Skin Substitute Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Skin Substitute Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
    • 16.5.1. Amarantus BioScience Holdings, Inc.
    • 16.5.2. Organogenesis, Inc
    • 16.5.3. Acelity L.P., Inc.
    • 16.5.4. Smith & Nephew plc
    • 16.5.5. BSN Medical GmbH
    • 16.5.6. Molnlycke Health Care ABss
    • 16.5.7. Integra LifeSciences Corporation
    • 16.5.8. Medtronic Plc
    • 16.5.9. Tissue Regenix Ltd.
    • 16.5.10. Stratatech Corporation

17. Strategic Recommendations